Arthur J. A. T. Braat

Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer

Ludwike W. M. van Kalmthout, Harm H.E. van Melick, Jules Lavalaye et al. · The Journal of Urology · 2019 · 105 citations

The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases

Maarten L. J. Smits, Mathijs G. Dassen, Jip F. Prince et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 98 citations · Full text

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity

Arthur J. A. T. Braat, S. Cheenu Kappadath, Hojjat Ahmadzadehfar et al. · CardioVascular and Interventional Radiology · 2019 · 89 citations

Neuroendocrine Liver, Hepatology, Radiation Therapy +10

68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617

Lisa H. de Vries, Lutske Lodewijk, Arthur J. A. T. Braat et al. · EJNMMI Research · 2020 · 78 citations · Full text

Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study

Arthur J. A. T. Braat, Rutger C. G. Bruijnen, Rob van Rooij et al. · The Lancet Oncology · 2020 · 74 citations

Hepatology, Additional Holmium-166 Radioembolisation, Medicine +13